Sjogren's Syndrome: More Than Just Dry Eye.
Akpek EK, Bunya VY, Saldanha IJ.
Cornea. 2019 May;38(5):658-661. doi: 10.1097/ICO.0000000000001865.
Primary Sjogren's syndrome and the eye.
Bjordal O, Norheim KB, Rødahl E, Jonsson R, Omdal R.
Surv Ophthalmol. 2020 Mar-Apr;65(2):119-132. doi: 10.1016/j.survophthal.2019.10.004. Epub 2019 Oct 18.
Dry Eye Syndrome Preferred Practice Pattern .
Amescua G, Ahmad S, Cheung AY, Choi DS, Jhanji V, Lin A, Mian SI, Rhee MK, Viriya ET, Mah FS, Varu DM; American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel.
Ophthalmology. 2024 Apr;131(4):P1-P49. doi: 10.1016/j.ophtha.2023.12.041. Epub 2024 Feb 12.
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).
[No authors listed]
Ocul Surf. 2007 Apr;5(2):75-92. doi: 10.1016/s1542-0124(12)70081-2.
Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
Chopra P, Fatima A, Mohapatra S, Murugaiyan K, Vemuganti GK, Rengan AK, Watson SL, Singh V, Basu S, Singh S.
Surv Ophthalmol. 2025 May-Jun;70(3):499-515. doi: 10.1016/j.survophthal.2025.01.003. Epub 2025 Jan 14.
Efficacy of topical mesenchymal stem cell exosome in Sjogren's syndrome-related dry eye: a randomized clinical trial.
Habibi A, Khosravi A, Soleimani M, Nejabat M, Dara M, Azarpira N.
BMC Ophthalmol. 2025 May 20;25(1):299. doi: 10.1186/s12886-025-04078-9.
Dry eye in Sjogren's syndrome - characteristics and therapy.
Caban M, Omulecki W, Latecka-Krajewska B.
Eur J Ophthalmol. 2022 Nov;32(6):3174-3184. doi: 10.1177/11206721221091375. Epub 2022 Mar 30.
Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjogren's syndrome: a randomized trial.
Kang MJ, Lee JH, Hwang J, Chung SH.
Sci Rep. 2023 Nov 7;13(1):19279. doi: 10.1038/s41598-023-46671-2.
ROS-Responsive Microneedle Patches Enable Peri-Lacrimal Gland Therapeutic Administration for Long-Acting Therapy of Sjogren's Syndrome-Related Dry Eye.
Mu J, Ding X, Song Y, Mi B, Fang X, Chen B, Yao B, Sun X, Yuan X, Guo S, Hua X.
Adv Sci (Weinh). 2025 Apr;12(16):e2409562. doi: 10.1002/advs.202409562. Epub 2025 Jan 10.
A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjogren's and Sjogren's syndrome dry eye disease.
Zhang D, Chen T, Liang Q, Feng X, Jiang J, Chen Z, Tang Y, Chu Y, Wang B, Hu K.
Stem Cell Res Ther. 2025 Apr 23;16(1):202. doi: 10.1186/s13287-025-04292-8.
